IDEXX LABORATORIES INC /DE Public Float
IDEXX LABORATORIES INC /DE (IDXX) had Public Float of $42.90 billion as of 2025-06-30, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-20
- 2025-06-30: Entity Public Float $42.90B.
- 2024-06-30: Entity Public Float $40.08B.
- 2023-06-30: Entity Public Float $41.33B.
- 2022-06-30: Entity Public Float $28.96B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $42.90B 10-K · filed 2026-02-20 |
| 2024-06-30 | $40.08B 10-K · filed 2025-02-21 |
| 2023-06-30 | $41.33B 10-K · filed 2024-02-22 |
| 2022-06-30 | $28.96B 10-K · filed 2023-02-16 |
| 2021-06-30 | $53.42B 10-K · filed 2022-02-16 |
| 2020-06-30 | $27.74B 10-K · filed 2021-02-12 |
| 2019-06-30 | $23.37B 10-K · filed 2020-02-14 |
| 2018-06-30 | $18.70B 10-K · filed 2019-02-15 |
| 2017-06-30 | $14.01B 10-K · filed 2018-02-16 |
| 2016-06-30 | $8.22B 10-K · filed 2017-02-17 |
| 2015-06-30 | $5.85B 10-K · filed 2016-02-17 |
| 2014-06-30 | $6.66B 10-K · filed 2015-02-17 |
| 2013-06-30 | $4.68B 10-K · filed 2014-02-18 |
| 2012-06-30 | $5.22B 10-K · filed 2013-02-19 |
| 2011-06-30 | $4.37B 10-K · filed 2012-02-17 |
| 2010-06-30 | $3.48B 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |